Last reviewed · How we verify

NCT05690230

Improving Patient Experience: BMBA

Completed NA Last updated 24 April 2025
What this trial tests

NA trial testing Virtual reality in Bone Marrow Cancer in 60 participants. Completed in 5 June 2024.

Timeline
5 December 2022
Primary endpoint
29 January 2024
5 June 2024

Quick facts

Lead sponsorThomas Jefferson University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment60
Start date5 December 2022
Primary completion29 January 2024
Estimated completion5 June 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Thomas Jefferson University

Who can join

18 and older, any sex, with Bone Marrow Cancer or Leukemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study seeks to determine if patients undergoing a bone marrow biopsy/aspiration (BMBA) procedure who receive distraction techniques have lower levels of distress and pain, and higher post-procedure satisfaction, compared to those receiving standard-of-care. Intervention 1 is guided meditation in a virtual reality (VR) headset. Intervention 2 is comprised of environmental changes to the room (via nature-themed decals) and music.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Virtual reality

Trials testing the same drug.

Other recruiting trials for Bone Marrow Cancer

Currently open trials in the same condition.

Other Thomas Jefferson University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05690230.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing